Revision as of 07:03, 1 September 2011 editBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot← Previous edit | Revision as of 07:14, 1 September 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or bugs)Next edit → | ||
Line 2: | Line 2: | ||
{{Drugbox | {{Drugbox | ||
| verifiedrevid = |
| verifiedrevid = 444523558 | ||
| IUPAC_name = 4-(dimethylamino)-2-isopropyl-2-phenylpentanenitrile | | IUPAC_name = 4-(dimethylamino)-2-isopropyl-2-phenylpentanenitrile | ||
| image = isoaminile.png | | image = isoaminile.png |
Revision as of 07:14, 1 September 2011
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Isoaminile" – news · newspapers · books · scholar · JSTOR (August 2009) (Learn how and when to remove this message) |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.940 |
Chemical and physical data | |
Formula | C16H24N2 |
Molar mass | 244.375 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Isoaminile (Peracon) is an antitussive structurally related to methadone. Psychedelic effects have been noted from doses approximately 300 mg and above. The normal therapeutic dose is 40-80 mg of the cyclamate salt not to exceed five doses in a 24-hour period. In addition to central antitussive effects it is also an anticholinergic, exhibiting both antimuscarinic and antinicotinic actions.
References
Hallucinogens | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
This drug article relating to the respiratory system is a stub. You can help Misplaced Pages by expanding it. |
This hallucinogen-related article is a stub. You can help Misplaced Pages by expanding it. |